Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BENJAMIN J OSBORNE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1750310504
CMS profile
306500
Location
WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$88,987.79

105 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
Alexion Pharmaceuticals, Inc. $27,747.25 31
Biogen, Inc. $26,796.71 21
Horizon Therapeutics plc $20,179.49 26
E.R. Squibb & Sons, L.L.C. $6,618.41 6
UCB, Inc. $4,050.00 2
Genentech USA, Inc. $2,751.13 3
EMD Serono, Inc. $365.31 6
Celgene Corporation $229.69 3
Novartis Pharmaceuticals Corporation $144.61 3
ABBVIE INC. $45.12 2
Genentech, Inc. $42.71 1
GENZYME CORPORATION $17.36 1

Page 2 of 3; records 51–100 of 105 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BENJAMIN J OSBORNE

NPI 1750310504 · CMS profile ID 306500

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 105 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1750310504?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BENJAMIN J OSBORNE, NPI 1750310504, CMS profile ID 306500. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 105 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1750310504?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). BENJAMIN J OSBORNE, NPI 1750310504, CMS profile ID 306500. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 105 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1750310504?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
BENJAMIN J OSBORNE, NPI 1750310504, CMS profile ID 306500, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 105 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1750310504?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

105 matching records · $88,987.79 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 105 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 105.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Horizon Therapeutics plc $39.5008/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937669419 CMS
Biogen, Inc. $77.2907/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923393171 CMS
EMD Serono, Inc. $105.5807/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941543171 CMS
Biogen, Inc. $3,256.5007/19/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923407947 CMS
Biogen, Inc. $4,008.0006/30/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923415759 CMS
Genentech USA, Inc. $108.0006/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950667407 CMS
Genentech USA, Inc. $2,530.0006/27/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950667411 CMS
Alexion Pharmaceuticals, Inc. $4.0006/15/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915481881 CMS
Alexion Pharmaceuticals, Inc. $3,640.0006/15/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915697021 CMS
Horizon Therapeutics plc $1,621.5006/14/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937669415 CMS
Horizon Therapeutics plc $400.0006/14/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937669417 CMS
Biogen, Inc. $41.6706/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923401093 CMS
Biogen, Inc. $7.2506/08/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923452757 CMS
Biogen, Inc. $3,507.0006/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923466803 CMS
Alexion Pharmaceuticals, Inc. $82.8906/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915809285 CMS
EMD Serono, Inc. $12.7806/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941521553 CMS
Horizon Therapeutics plc $42.7806/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937669413 CMS
Novartis Pharmaceuticals Corporation $34.5806/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894047057 CMS
Celgene Corporation $95.0306/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932878955 CMS
Horizon Therapeutics plc $42.4006/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937669405 CMS
Horizon Therapeutics plc $23.9206/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937669407 CMS
Horizon Therapeutics plc $52.7606/01/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937669409 CMS
Horizon Therapeutics plc $3,000.0006/01/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937669411 CMS
Alexion Pharmaceuticals, Inc. $87.7205/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914958115 CMS
Alexion Pharmaceuticals, Inc. $1,120.0005/13/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914640389 CMS
Biogen, Inc. $48.1105/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923389123 CMS
Biogen, Inc. $21.4705/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923409237 CMS
Biogen, Inc. $3,507.0005/05/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923462667 CMS
Biogen, Inc. $9.3505/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923406167 CMS
UCB, Inc. $2,025.0004/15/2022 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1155525210 CMS
UCB, Inc. $2,025.0004/15/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908109839 CMS
E.R. Squibb & Sons, L.L.C. $3,120.0004/12/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932878975 CMS
E.R. Squibb & Sons, L.L.C. $8.7503/28/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932878977 CMS
E.R. Squibb & Sons, L.L.C. $41.4303/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932878979 CMS
Horizon Therapeutics plc $1,621.5003/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937669401 CMS
Horizon Therapeutics plc $1,621.5003/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937669403 CMS
Alexion Pharmaceuticals, Inc. $3,920.0003/15/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914969675 CMS
Alexion Pharmaceuticals, Inc. $1,680.0003/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914837947 CMS
Celgene Corporation $125.0002/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932878899 CMS
E.R. Squibb & Sons, L.L.C. $28.2302/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932878913 CMS
GENZYME CORPORATION $17.3602/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938961099 CMS
Horizon Therapeutics plc $104.2502/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937669399 CMS
EMD Serono, Inc. $33.0202/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941494795 CMS
Novartis Pharmaceuticals Corporation $32.5602/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894047049 CMS
Novartis Pharmaceuticals Corporation $77.4702/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894047053 CMS
Biogen, Inc. $4,008.0002/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923383807 CMS
Biogen, Inc. $25.3902/21/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923451975 CMS
Biogen, Inc. $40.9202/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923458745 CMS
Horizon Therapeutics plc $49.7302/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937669397 CMS
Biogen, Inc. $45.8602/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923426573 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $88,627.80 125
PY2020 $81,382.62 73
PY2021 $54,764.89 50
PY2022 $88,987.79 105
PY2023 $179,187.05 193
PY2024 $150,238.35 192
PY2025 $103,351.39 136

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $267,218.84 14
PY2024 Principal investigator $125,676.81 19
PY2023 Principal investigator $106,979.67 11
PY2022 Principal investigator $40,450.00 1
PY2021 Principal investigator $64,727.29 22
PY2020 Principal investigator $72,657.43 2
PY2019 Principal investigator $75,130.95 26

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Alexion Pharmaceuticals, Inc. $488.50 12/12/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Long-Term, Prospective, Observational, Registry of Patients with Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated with Alexion Complement Component 5 (C5) Inhibitor Therapies (ALXN-C5IT) No dispute reported 06/30/2026 1185546399
Principal investigator 1 Genentech, Inc. $1,534.00 12/11/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY GEORGETOWN UNIV CLINICAL TRIALS
Satralizumab in MOG AD No dispute reported 06/30/2026 1211610437
Principal investigator 1 Genentech, Inc. $11,839.00 11/13/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY GEORGETOWN UNIV CLINICAL TRIALS
Satralizumab in MOG AD No dispute reported 06/30/2026 1211610434
Principal investigator 1 UCB SA $409.34 10/06/2025 Non-covered Recipient Entity
MEDSTAR GEORGETOWN UNIVERSITY HOSPITAL - NEUROLOGY
A randomized, double-blind, placebo-controlled, multicenter, phase 3, pivotal study with an open-lable extension period to evaluate the efficacy and safety of rozanolixizumab in adult participants with myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOG-AD) No dispute reported 06/30/2026 1246658810
Principal investigator 1 Genentech, Inc. $12,240.00 09/02/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY GEORGETOWN UNIV CLINICAL TRIALS
Satralizumab in NMOSD patients 100kg No dispute reported 06/30/2026 1211610370
Principal investigator 1 Genentech, Inc. $44,706.00 08/21/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY GEORGETOWN UNIV CLINICAL TRIALS
Satralizumab in MOG AD No dispute reported 06/30/2026 1211610429
Principal investigator 1 Genentech, Inc. $14,226.00 07/29/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY GEORGETOWN UNIV CLINICAL TRIALS
Satralizumab in NMOSD patients 100kg No dispute reported 06/30/2026 1211610365
Principal investigator 1 Genentech, Inc. $3,460.00 07/01/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY GEORGETOWN UNIV CLINICAL TRIALS
Satralizumab in MOG AD No dispute reported 06/30/2026 1211610410
Principal investigator 1 Genentech, Inc. $12,740.00 04/29/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY GEORGETOWN UNIV CLINICAL TRIALS
Satralizumab in MOG AD No dispute reported 06/30/2026 1211610425
Principal investigator 1 Genentech, Inc. $31,069.00 04/28/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY GEORGETOWN UNIV CLINICAL TRIALS
Satralizumab in MOG AD No dispute reported 06/30/2026 1211610421
Principal investigator 1 UCB SA $61,959.00 02/05/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A randomized, double-blind, placebo-controlled, multicenter, phase 3, pivotal study with an open-lable extension period to evaluate the efficacy and safety of rozanolixizumab in adult participants with myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOG-AD) No dispute reported 06/30/2026 1246658340
Principal investigator 1 Alexion Pharmaceuticals, Inc. $7,981.00 01/22/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY MEDICAL CENTER
A Long-Term, Prospective, Observational, Registry of Patients with Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated with Alexion Complement Component 5 (C5) Inhibitor Therapies (ALXN-C5IT) No dispute reported 06/30/2026 1185546397
Principal investigator 1 Genentech, Inc. $36,472.00 01/22/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY GEORGETOWN UNIV CLINICAL TRIALS
Satralizumab in MOG AD No dispute reported 06/30/2026 1211610414
Principal investigator 1 Genentech, Inc. $28,095.00 01/17/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY GEORGETOWN UNIV CLINICAL TRIALS
Satralizumab in MOG AD No dispute reported 06/30/2026 1211610417